Vitamin K4 Tablets

This product is a vitamin drug. Vitamin K, as a coenzyme of carboxylase, participates in the synthesis of coagulation factors II, VII, IX, and X. The glutamic acid residues on these factors must form 912 gamma-carboxyglutamic acids under the action of the carboxylase system of the liver microsomal enzyme system, so that these factors can bind to Ca2 and connect to the phospholipid surface and regulatory proteins, so that these factors have coagulation activity, thereby producing a coagulation effect. If vitamin K4 is deficient or the epoxide reduction reaction is blocked (such as antagonism by coumarins), the synthesis of factors II, VII, IX, and X will remain in the precursor state, and the prothrombin time will be prolonged, causing bleeding.

The main ingredient of this product is vitamin K4, and its chemical name is menadione acetate.

This product is brown or white sugar-coated tablets.

Used for vitamin K deficiency and hypoprothrombinemia.

Oral administration. 2-4 mg each time, 3 times a day. Preoperative treatment of obstructive jaundice, 10-20 mg daily for one week.

Allergic reactions may occur occasionally.

It is contraindicated in patients with severe liver disease or hepatic insufficiency.

Oral anticoagulants (such as dicoumarol) can antagonize the effect of this product. Salicylic acid, sulfonamides, quinine, quinidine, etc. also affect the effect of vitamin K4.

Store at room temperature, away from light.

2mg

Kaifeng MINGREN Pharmaceuticals Co., Ltd.

• Founded in:

  2002-11-08

• Address:

  No. 8, Yuanqu Road, Huanglong Park, Kaifeng Economic Development Zone

• Tax NO.:

  91410212744078206P

• Registered Funds:

  50 million yuan

• Website:

  Log in to view

• Email:

  Log in to view